2022 Q3 Form 10-Q Financial Statement

#000165495422010468 Filed on August 02, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $19.00K $0.00
YoY Change -100.0% 171.43%
Cost Of Revenue $1.655M $1.662M $1.722M
YoY Change -2.82% -9.43% 2.93%
Gross Profit -$1.655M -$1.643M -$1.722M
YoY Change -2.3% -10.12% 2.93%
Gross Profit Margin -8647.37%
Selling, General & Admin $1.186M $1.561M $2.026M
YoY Change -13.3% -4.12% 85.87%
% of Gross Profit
Research & Development $1.610M $1.786M $1.160M
YoY Change 129.34% 74.07% 93.33%
% of Gross Profit
Depreciation & Amortization $765.0K $765.0K $456.0K
YoY Change -19.64% -19.39% 2.24%
% of Gross Profit
Operating Expenses $2.910M $3.460M $3.298M
YoY Change 32.94% 24.59% 82.01%
Operating Profit -$4.565M -$5.103M -$5.020M
YoY Change 17.56% 10.81% 44.05%
Interest Expense $114.0K $163.0K $174.0K
YoY Change -37.36% -12.83% -7.94%
% of Operating Profit
Other Income/Expense, Net -$7.000K $4.000K $1.250M
YoY Change -450.0% 300.0%
Pretax Income -$4.962M -$353.0K -$6.928M
YoY Change -45.52% -94.87% -6.0%
Income Tax
% Of Pretax Income
Net Earnings -$4.962M -$353.0K -$6.928M
YoY Change -45.52% -94.87% -6.02%
Net Earnings / Revenue -1857.89%
Basic Earnings Per Share -$0.03 $0.00 -$0.03
Diluted Earnings Per Share -$0.03 $0.00 -$0.03
COMMON SHARES
Basic Shares Outstanding 222.8M shares 219.1M shares 217.3M shares
Diluted Shares Outstanding 221.8B shares 219.1M shares 217.3M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $39.92M $43.27M $46.32M
YoY Change 19.47% 101.33% 163.15%
Cash & Equivalents $39.92M $43.27M $46.32M
Short-Term Investments
Other Short-Term Assets $1.375M $2.673M $2.588M
YoY Change -49.65% -23.03% 331.33%
Inventory $9.903M $7.923M
Prepaid Expenses $1.375M $1.137M
Receivables $4.000K $15.00K $6.000K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $51.20M $53.88M $48.91M
YoY Change 41.6% 115.78% 168.63%
LONG-TERM ASSETS
Property, Plant & Equipment $20.10M $20.43M $20.86M
YoY Change -2.38% -2.75% -2.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $8.065M $8.026M $15.94M
YoY Change -48.9% -49.14% 1.55%
Total Long-Term Assets $64.13M $62.90M $71.56M
YoY Change -10.39% -13.29% -5.63%
TOTAL ASSETS
Total Short-Term Assets $51.20M $53.88M $48.91M
Total Long-Term Assets $64.13M $62.90M $71.56M
Total Assets $115.3M $116.8M $120.5M
YoY Change 7.06% 19.76% 28.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.275M $1.429M $1.367M
YoY Change 553.85% 119.17% 263.56%
Accrued Expenses $2.040M $2.062M $2.298M
YoY Change -0.92% -2.0% 9.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.333M $3.971M $2.628M
YoY Change 226.87%
Total Short-Term Liabilities $8.605M $8.568M $9.327M
YoY Change 33.85% 48.31% 77.49%
LONG-TERM LIABILITIES
Long-Term Debt $7.108M $8.470M $9.813M
YoY Change -42.26% 9913.27%
Other Long-Term Liabilities $33.12M $33.15M $36.23M
YoY Change -10.73% -12.4% 0.07%
Total Long-Term Liabilities $40.18M $41.56M $45.97M
YoY Change -18.67% -17.11% -5.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.605M $8.568M $9.327M
Total Long-Term Liabilities $40.18M $41.56M $45.97M
Total Liabilities $48.79M $50.13M $55.30M
YoY Change -12.63% -10.35% 2.6%
SHAREHOLDERS EQUITY
Retained Earnings -$215.4M -$210.4M -$210.0M
YoY Change 5.81% 8.21% 11.99%
Common Stock $256.8M
YoY Change 1110.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $66.54M $66.65M $65.17M
YoY Change
Total Liabilities & Shareholders Equity $115.3M $116.8M $120.5M
YoY Change 7.06% 19.76% 28.11%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$4.962M -$353.0K -$6.928M
YoY Change -45.52% -94.87% -6.02%
Depreciation, Depletion And Amortization $765.0K $765.0K $456.0K
YoY Change -19.64% -19.39% 2.24%
Cash From Operating Activities -$5.940M -$4.174M -$2.222M
YoY Change 77.74% 12.48% 7.03%
INVESTING ACTIVITIES
Capital Expenditures -$128.0K -$25.00K -$60.00K
YoY Change 433.33% -35.9%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$128.0K -$25.00K -$60.00K
YoY Change 433.33% -35.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.858M 1.211M $2.440M
YoY Change -81.35% -84.13% -84.12%
NET CHANGE
Cash From Operating Activities -5.940M -4.174M -$2.222M
Cash From Investing Activities -128.0K -25.00K -$60.00K
Cash From Financing Activities 2.858M 1.211M $2.440M
Net Change In Cash -3.210M -2.988M $180.0K
YoY Change -126.85% -176.99% -98.65%
FREE CASH FLOW
Cash From Operating Activities -$5.940M -$4.174M -$2.222M
Capital Expenditures -$128.0K -$25.00K -$60.00K
Free Cash Flow -$5.812M -$4.149M -$2.162M
YoY Change 75.17% 12.99% 4.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
1536000 usd
CY2021Q4 urg Cash Pledged For Reclamation
CashPledgedForReclamation
7966000 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
8026000 usd
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
7966000 usd
CY2021Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
35067000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
-624000 usd
CY2022Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
34443000 usd
us-gaap Accretion Expense
AccretionExpense
246000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6758000 usd
us-gaap Development Costs
DevelopmentCosts
465000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3585000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2722000 usd
us-gaap Accretion Expense
AccretionExpense
225000 usd
us-gaap Exploration Expense
ExplorationExpense
1156000 usd
us-gaap Development Costs
DevelopmentCosts
1949000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4589000 usd
CY2022Q2 urg Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price66
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice66
0.69
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33905
dei Entity Registrant Name
EntityRegistrantName
UR-ENERGY INC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
dei Entity Address Address Line1
EntityAddressAddressLine1
10758 West Centennial Road
urg Proceeds From Options Exercised
ProceedsFromOptionsExercised
200000 usd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Littleton
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
urg Proceeds From Options Exercised
ProceedsFromOptionsExercised
1200000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
300000 usd
urg Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
216782694 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
219246028 shares
urg Disposal Billings
DisposalBillings
7000 usd
CY2022Q2 urg Disposal Billings
DisposalBillings
19000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001375205
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
urg Number Of Rsus Unvested Granted
NumberOfRsusUnvestedGranted
0 shares
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
500000 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.72
CY2022Q2 urg Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number75
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber75
9918999 shares
CY2021Q4 us-gaap Partners Capital
PartnersCapital
248319000 usd
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80127
dei City Area Code
CityAreaCode
720
dei Local Phone Number
LocalPhoneNumber
981-4588
dei Security12b Title
Security12bTitle
Common stock
dei Trading Symbol
TradingSymbol
URG
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
222806028 shares
CY2022Q2 us-gaap Inventory Net
InventoryNet
7923000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
0 usd
CY2022Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
34443000 usd
CY2021Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
35067000 usd
CY2022Q2 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
20427000 usd
CY2021Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
21260000 usd
CY2022Q2 us-gaap Assets
Assets
116774000 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
8416000 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
11060000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
40384000 usd
CY2022Q2 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
19957000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20427000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
40367000 usd
CY2021Q4 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
19107000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21260000 usd
CY2022Q2 us-gaap Partners Capital
PartnersCapital
252182000 usd
us-gaap Revenues
Revenues
19000 usd
CY2021Q2 us-gaap Revenues
Revenues
7000 usd
CY2022Q2 us-gaap Revenues
Revenues
19000 usd
us-gaap Revenues
Revenues
7000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
1662000 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
1835000 usd
us-gaap Cost Of Revenue
CostOfRevenue
3384000 usd
us-gaap Cost Of Revenue
CostOfRevenue
3508000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
-1643000 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
-1828000 usd
us-gaap Gross Profit
GrossProfit
-3365000 usd
us-gaap Gross Profit
GrossProfit
-3501000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
3460000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
2777000 usd
us-gaap Operating Expenses
OperatingExpenses
6758000 usd
us-gaap Operating Expenses
OperatingExpenses
4589000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5103000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4605000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10123000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8090000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
163000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
187000 usd
us-gaap Interest Expense
InterestExpense
337000 usd
us-gaap Interest Expense
InterestExpense
376000 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4888000 usd
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2920000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1915000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
6324000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
21000 usd
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-71000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
10000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-367000 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
4000 usd
CY2021Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
904000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1254000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
906000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7281000 usd
us-gaap Net Income Loss
NetIncomeLoss
-14251000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-7231000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-353000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-6879000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
158000 usd
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
34000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
50000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
253000 usd
CY2022Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-195000 usd
CY2021Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-6845000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-13998000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
219146082 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
190240544 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218205337 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
186089756 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
219146082 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
190240544 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
218205337 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
186089756 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
34096000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1078000 usd
CY2021Q1 urg Exercise Of Warrants Amount
ExerciseOfWarrantsAmount
551000 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15237000 usd
CY2021Q1 urg Less Amount Assigned To Warrant Liability Amount
LessAmountAssignedToWarrantLiabilityAmount
-2604000 usd
CY2021Q1 urg Less Share Issue Costs
LessShareIssueCosts
-1307000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
231000 usd
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7153000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
40129000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
94000 usd
CY2021Q2 urg Exercise Of Warrants Amount
ExerciseOfWarrantsAmount
1245000 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6930000 usd
CY2021Q2 urg Less Share Issue Costs
LessShareIssueCosts
-218000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
259000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6845000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
41594000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
69386000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
171000 usd
CY2022Q1 urg Exercise Of Warrants Amount
ExerciseOfWarrantsAmount
308000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2128000 usd
CY2022Q1 urg Less Share Issue Costs
LessShareIssueCosts
-53000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
261000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7036000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
65165000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
56000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1185000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1429000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
854000 usd
CY2022Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1816000 usd
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1927000 usd
CY2022Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
175000 usd
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
83000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3420000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2864000 usd
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
3971000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1305000 usd
CY2021Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
43000 usd
CY2022Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
43000 usd
CY2022Q2 us-gaap Loans Payable Current
LoansPayableCurrent
3928000 usd
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
1262000 usd
CY2022Q2 urg Less Share Issue Costs
LessShareIssueCosts
-30000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
464000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-195000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
66645000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7281000 usd
us-gaap Net Income Loss
NetIncomeLoss
-14251000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
725000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
490000 usd
us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
3384000 usd
us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
3508000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
624000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1017000 usd
us-gaap Depreciation
Depreciation
909000 usd
us-gaap Depreciation
Depreciation
892000 usd
us-gaap Accretion Expense
AccretionExpense
225000 usd
us-gaap Accretion Expense
AccretionExpense
246000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
22000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
24000 usd
urg Gain On Loan Forgiveness
GainOnLoanForgiveness
0 usd
urg Gain On Loan Forgiveness
GainOnLoanForgiveness
-903000 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
1915000 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-6324000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
7000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-369000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3384000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3616000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
243000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
246000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
556000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
360000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6396000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5791000 usd
us-gaap Payments To Acquire Oil And Gas Property And Equipment
PaymentsToAcquireOilAndGasPropertyAndEquipment
85000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-85000 usd
us-gaap Payments To Acquire Oil And Gas Property And Equipment
PaymentsToAcquireOilAndGasPropertyAndEquipment
39000 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
3313000 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
22167000 usd
urg Share Issue Costs
ShareIssueCosts
-83000 usd
urg Share Issue Costs
ShareIssueCosts
-1525000 usd
urg Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
421000 usd
urg Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
2359000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3651000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23001000 usd
urg Effects Of Foreign Exchange Rate Changes On Cash
EffectsOfForeignExchangeRateChangesOnCash
-32000 usd
urg Effects Of Foreign Exchange Rate Changes On Cash
EffectsOfForeignExchangeRateChangesOnCash
53000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2862000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17224000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54155000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12127000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51293000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29351000 usd
CY2021Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
29915000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>1. Nature of Operations</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">Ur-Energy Inc. (the “Company”) was incorporated on March 22, 2004, under the laws of the Province of Ontario. The Company continued under the Canada Business Corporations Act on August 8, 2006. The Company is an exploration stage issuer, as defined by United States Securities and Exchange Commission (“SEC”). The Company is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located primarily in Wyoming. The Company commenced uranium production at its Lost Creek Project in Wyoming in 2013.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">Due to the nature of the uranium recovery methods used by the Company on the Lost Creek Property, and the definition of “mineral reserves” under Subpart 1300 to Regulation S-K (“S-K 1300”), the Company has not determined whether the properties contain mineral reserves. This was true while the Company reported its mineral resources pursuant to Canadian National Instrument 43-101 (“NI 43-101”). The Company’s report <em>The Lost Creek ISR Uranium Property, Sweetwater County, Wyoming,</em> March 7, 2022 (the “Lost Creek Report”) outlines the potential viability of the Lost Creek Property. The recoverability of amounts recorded for mineral properties is dependent upon the discovery of economic resources, the ability of the Company to obtain the necessary financing to develop the properties and upon attaining future profitable production from the properties or sufficient proceeds from disposition of the properties.</p>
CY2022Q2 us-gaap Cash
Cash
6287000 usd
CY2021Q4 us-gaap Cash
Cash
9068000 usd
CY2022Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
36980000 usd
CY2021Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
37121000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43267000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46189000 usd
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8470000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11136000 usd
CY2022Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
54000 usd
CY2021Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
76000 usd
CY2022Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
8416000 usd
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
11060000 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
225000 usd
CY2022Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
30140000 usd
us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
3384000 usd
us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
3508000 usd
CY2022Q2 us-gaap Assets Held In Trust
AssetsHeldInTrust
1536000 usd
CY2022Q2 urg Cash Pledged For Reclamation
CashPledgedForReclamation
8026000 usd
urg Beginning Balance Warrant Liabilities
BeginningBalanceWarrantLiabilities
6263000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
114000 usd
urg Mark To Market Revaluation Loss Gain
MarkToMarketRevaluationLossGain
-1915000 usd
us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
89000 usd
urg Ending Balance Warrant Liabilities
EndingBalanceWarrantLiabilities
4145000 usd
CY2022Q2 urg Current Portion Of Warrant Liability
CurrentPortionOfWarrantLiability
1149000 usd
CY2022Q2 urg Warrant Liability
WarrantLiability
2996000 usd
CY2022Q2 urg Total
Total
4145000 usd
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
219246028 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
216782694 shares
CY2021Q1 urg Shares Issued Upon Public Offering
SharesIssuedUponPublicOffering
14722200 shares
CY2021Q1 urg Warrants Issued To Purchase Common Shares
WarrantsIssuedToPurchaseCommonShares
7361100 shares
CY2021Q1 us-gaap Accelerated Share Repurchases Initial Price Paid Per Share
AcceleratedShareRepurchasesInitialPricePaidPerShare
0.90
CY2021Q1 urg Common Stock No Par Values
CommonStockNoParValues
1.35
CY2021Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2208330 shares
CY2021Q1 us-gaap Investment Sold Not Yet Purchased Balance Shares
InvestmentSoldNotYetPurchasedBalanceShares
1104165 shares
urg Warrants Issued To Purchase Common Shares
WarrantsIssuedToPurchaseCommonShares
16930530 shares
CY2021Q1 urg Common Shares Purchase
CommonSharesPurchase
8465265 shares
CY2021Q1 urg Proceed From Warrant Exercises
ProceedFromWarrantExercises
15200000 usd
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
1300000 usd
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
13900000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
300000 usd
urg Unamortized Stock Based Comoensation Expenses
UnamortizedStockBasedComoensationExpenses
900000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10064024 shares
CY2021Q4 urg Outstanding Beginning Balance Weighted Average Exercise Price
OutstandingBeginningBalanceWeightedAverageExercisePrice
0.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
175000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.74
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
320025 shares
urg Option Weighted Average Vesting Period
OptionWeightedAverageVestingPeriod
P1Y10M24D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.69
CY2022Q2 urg Number Of Options Outstanding
NumberOfOptionsOutstanding
9918999 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y6M
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3870593 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6322402 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y10M24D
urg Aggregate Intrinsic Value Exercisable
AggregateIntrinsicValueExercisable
2653072 usd
CY2022Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.06
CY2022Q2 urg Number Of Options Outstandings
NumberOfOptionsOutstandings
8421835 shares
CY2022Q2 urg Number Of Options Exercisable
NumberOfOptionsExercisable
6133117 shares
urg Schedule Of Stock Option Fair Value Assumptionstabletextblock
ScheduleOfStockOptionFairValueAssumptionstabletextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Stock Options Fair Value Assumptions </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong> 2022 </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong> 2021 </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected forfeiture rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6.1</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected life (years) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected volatility </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">72.7</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">69.5</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Risk free rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.9</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.7</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected dividend rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Black-Scholes value (CAD$) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"/><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">$1.22</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"/><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">$0.74</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
urg Sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpected Forfeiture Rate
SharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedForfeitureRate
0.056 pure
urg Sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpected Forfeiture Rate
SharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedForfeitureRate
0.061 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.727 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.695 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.019 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.007 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
urg Black Scholes Value Cad
BlackScholesValueCad
1.22
urg Black Scholes Value Cad
BlackScholesValueCad
0.74
urg Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Beginning
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBeginning
1011660 shares
urg Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Beginning
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueBeginning
0.69
urg Granted Weighted Average Grant Date Fair Value
GrantedWeightedAverageGrantDateFairValue
0.00
urg Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedWeightedAverageGrantDateFairValue
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.00
urg Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Ending
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberEnding
1011660 shares
urg Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Ending
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueEnding
0.69
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1011660 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P0Y7M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
1072360000 usd
CY2022Q2 us-gaap Development Costs
DevelopmentCosts
1326000 usd
CY2021Q2 us-gaap Development Costs
DevelopmentCosts
333000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1561000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1628000 usd
CY2021Q1 urg Class Of Warrant Or Right Exercise Price Of Warrants
ClassOfWarrantOrRightExercisePriceOfWarrants
1.35
urg Restricted Share Unit Fair Value Assumptions Expected Forfeiture Rate
RestrictedShareUnitFairValueAssumptionsExpectedForfeitureRate
0.044 pure
urg Restricted Share Unit Fair Value Assumptions Expected Forfeiture Rate
RestrictedShareUnitFairValueAssumptionsExpectedForfeitureRate
0.042 pure
urg Restricted Share Unit Fair Value Assumptions Grant Date Fair Value Cad
RestrictedShareUnitFairValueAssumptionsGrantDateFairValueCad
1.44
urg Restricted Share Unit Fair Value Assumptions Grant Date Fair Value Cad
RestrictedShareUnitFairValueAssumptionsGrantDateFairValueCad
0.63
CY2020Q3 urg Class Of Warrant Or Right Exercise Price Of Warrants
ClassOfWarrantOrRightExercisePriceOfWarrants
0.75
urg Class Of Warrant Or Right Outstanding Beginning
ClassOfWarrantOrRightOutstandingBeginning
24368530 shares
urg Class Of Warrants Or Right Shares Issued On Exercise Beginning
ClassOfWarrantsOrRightSharesIssuedOnExerciseBeginning
12184265 shares
urg Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Beginning
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Beginning
1.16
urg Number Of Warrants Exercised
NumberOfWarrantsExercised
-518000 shares
urg Number Of Shares To Be Issued Upon Exercise Exercised
NumberOfSharesToBeIssuedUponExerciseExercised
-259000 shares
urg Per Share Exercise Price Exercised
PerShareExercisePriceExercised
0.75
urg Class Of Warrant Or Right Outstanding Ending
ClassOfWarrantOrRightOutstandingEnding
23850530 shares
urg Class Of Warrants Or Right Shares Issued On Exercise Ending
ClassOfWarrantsOrRightSharesIssuedOnExerciseEnding
11925265 shares
urg Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Ending
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Ending
1.17
urg Disposal Billings
DisposalBillings
19000 usd
CY2021Q2 urg Disposal Billings
DisposalBillings
7000 usd
CY2021Q2 us-gaap Accretion Expense
AccretionExpense
123000 usd
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3460000 usd
CY2021Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2777000 usd
CY2022Q2 urg Cost Of Product Sale
CostOfProductSale
0 usd
urg Cost Of Product Sale
CostOfProductSale
0 usd
urg Cost Of Product Sale
CostOfProductSale
0 usd
CY2021Q2 urg Cost Of Product Sale
CostOfProductSale
0 usd
CY2022Q2 urg Lower Of Cost Or Nrv Adjustments
LowerOfCostOrNRVAdjustments
1662000 usd
CY2021Q2 urg Lower Of Cost Or Nrv Adjustments
LowerOfCostOrNRVAdjustments
1835000 usd
urg Lower Of Cost Or Nrv Adjustments
LowerOfCostOrNRVAdjustments
3384000 usd
urg Lower Of Cost Or Nrv Adjustments
LowerOfCostOrNRVAdjustments
3508000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1662000 usd
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1835000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3384000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3508000 usd
CY2022Q2 us-gaap Exploration Expense
ExplorationExpense
460000 usd
CY2021Q2 us-gaap Exploration Expense
ExplorationExpense
693000 usd
us-gaap Exploration Expense
ExplorationExpense
999000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43267000 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21491000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
8026000 usd
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7860000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51293000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29351000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
400000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
400000 usd
CY2022Q2 urg Deposit Held In Canada And Us
DepositHeldInCanadaAndUs
600000 usd

Files In Submission

Name View Source Status
0001654954-22-010468-index-headers.html Edgar Link pending
0001654954-22-010468-index.html Edgar Link pending
0001654954-22-010468.txt Edgar Link pending
0001654954-22-010468-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
urg-20220630.xsd Edgar Link pending
urg-20220630_cal.xml Edgar Link unprocessable
urg-20220630_def.xml Edgar Link unprocessable
urg-20220630_lab.xml Edgar Link unprocessable
urg-20220630_pre.xml Edgar Link unprocessable
urg_10q.htm Edgar Link pending
urg_10q_htm.xml Edgar Link completed
urg_ex311.htm Edgar Link pending
urg_ex312.htm Edgar Link pending
urg_ex321.htm Edgar Link pending
urg_ex322.htm Edgar Link pending